240 related articles for article (PubMed ID: 9108406)
1. C3a and C5a stimulate chemotaxis of human mast cells.
Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
[TBL] [Abstract][Full Text] [Related]
2. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
3. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
[TBL] [Abstract][Full Text] [Related]
4. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein.
Norgauer J; Dobos G; Kownatzki E; Dahinden C; Burger R; Kupper R; Gierschik P
Eur J Biochem; 1993 Oct; 217(1):289-94. PubMed ID: 8223566
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
7. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
8. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.
Nilsson G; Metcalfe DD; Taub DD
Immunology; 2000 Feb; 99(2):314-9. PubMed ID: 10692052
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.
Xie P; Nishiura H; Semba U; Chen J; Zhao R; Kuniyasu A; Yamamoto T
Int Immunopharmacol; 2012 Jan; 12(1):158-68. PubMed ID: 22155625
[TBL] [Abstract][Full Text] [Related]
10. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.
Venkatesha RT; Berla Thangam E; Zaidi AK; Ali H
Mol Immunol; 2005 Mar; 42(5):581-7. PubMed ID: 15607817
[TBL] [Abstract][Full Text] [Related]
11. C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1.
Ahamed J; Venkatesha RT; Thangam EB; Ali H
J Immunol; 2004 Jun; 172(11):6961-8. PubMed ID: 15153516
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
13. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
14. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins.
Elsner J; Oppermann M; Czech W; Kapp A
Blood; 1994 Jun; 83(11):3324-31. PubMed ID: 8193368
[TBL] [Abstract][Full Text] [Related]
15. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
[TBL] [Abstract][Full Text] [Related]
16. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
17. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia.
Möller T; Nolte C; Burger R; Verkhratsky A; Kettenmann H
J Neurosci; 1997 Jan; 17(2):615-24. PubMed ID: 8987784
[TBL] [Abstract][Full Text] [Related]
19. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.
Thangam EB; Venkatesha RT; Zaidi AK; Jordan-Sciutto KL; Goncharov DA; Krymskaya VP; Amrani Y; Panettieri RA; Ali H
FASEB J; 2005 May; 19(7):798-800. PubMed ID: 15758041
[TBL] [Abstract][Full Text] [Related]
20. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
